NOVOZYMES AS/FI - COM (NVZMY)

CUSIP: 670108109

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
356,764
Share change
-76,618
Total reported value
$20,628,000
Price per share
$57.80
Number of holders
15
Value change
-$3,994,103
Number of buys
5
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 670108109?
CUSIP 670108109 identifies NVZMY - NOVOZYMES AS/FI - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVOZYMES AS/FI - COM (NVZMY) as of Q2 2020

As of 30 Jun 2020, NOVOZYMES AS/FI - COM (NVZMY) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 356,764 shares. The largest 10 holders included Parametric Portfolio Associates LLC, ZEVIN ASSET MANAGEMENT LLC, HANTZ FINANCIAL SERVICES, INC., PNC Financial Services Group, Inc., Douglass Winthrop Advisors, LLC, Hemenway Trust Co LLC, Moloney Securities Asset Management, LLC, HIGH POINTE CAPITAL MANAGEMENT LLC, ST GERMAIN D J CO INC, and CAPTRUST FINANCIAL ADVISORS. This page lists 15 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.